Skip to main content

. 1958 May 31;1(5082):1270-3, 1274-1277. doi: 10.1136/bmj.1.5082.1274

Nephrotic Syndrome Complicating Mercurial Diuretic Therapy

Margaret Riddle, Frances Gardner, Isobel Beswick, Ian Filshie

PMCID: PMC2028853 PMID: 13536476

1270-3

Images in this article

Fig. 1
on p.1270-3

Fig. 2
on p.1270-3

Fig. 3
on p.1270-3

Fig. 4
on p.1270-3

Fig. 1
on p.1270-3

Fig. 2
on p.1270-3

Fig. 3
on p.1270-3

Fig. 4
on p.1270-3

Fig. 5
on p.1270-3

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

DIENGOTT D. Dangers in the use of mercurial diuretics, with emphasis on the importance of hypoalbuminemia in the etiology of complication; review and presentation of a case. Harefuah. 1953 May 15;44(10):227–230. [PubMed] [Google Scholar]
MOYER J. H., HANDLEY C. A., SEIBERT R. A., SYNDER H. B. Electrolyte, water, and mercury excretion after oral administration of neohydrin; observations on experimental use of neohydrin (1347ex), a chloro derivative, and two thiol (1353ex and 1431ex) derivatives of 2-methoxy-propylurea. AMA Arch Intern Med. 1953 Dec;92(6):847–855. doi: 10.1001/archinte.1953.00240240083006. [DOI] [PubMed] [Google Scholar]
MUNCK O., NISSEN N. I. Development of nephrotic syndrome during treatment with mercurial diuretics. Acta Med Scand. 1956 Jan 25;153(4):307–313. doi: 10.1111/j.0954-6820.1955.tb18231.x. [DOI] [PubMed] [Google Scholar]
PREEDY J. R., RUSSELL D. S. Acute salt depletion associated with the nephrotic syndrome developing during treatment with a mercurial diuretic. Lancet. 1953 Dec 5;265(6797):1181–1184. doi: 10.1016/s0140-6736(53)90730-2. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES